Primerica, INC
Market Movers (8-K)
NYSE
Primerica, Inc. has amended and restated its $200 million unsecured revolving credit facility, extending the maturity date to June 2, 2031, and adjusting key financial covenants and margins.
NYSE
Primerica, Inc. held its 2026 annual stockholders meeting, where directors were elected, executive compensation was approved, and the independent auditor was ratified.
NYSE
Primerica Inc. announced robust first-quarter 2026 financial results, driven by record sales in its Investment and Savings Products segment and stable performance in Term Life Insurance.
NYSE
Primerica, Inc. has adopted new bylaws requiring a majority of voting power for shareholders to call a special meeting, while also detailing proxy access rules.
NYSE
Primerica, Inc. announced robust fourth-quarter and full-year 2025 financial results, driven by record Investment and Savings Products sales and increased capital returns to shareholders.
Capital raise
Better than expected
NYSE
Primerica, Inc. announced that long-serving directors Beatriz R. Perez and Gary L. Crittenden will not seek re-election at the upcoming May 2026 annual meeting.
Quarterly Earnings (10-Q)
NYSE
Primerica, Inc. announced a 12% increase in net income for the first quarter of 2026, driven by robust growth in its Investment and Savings Products segment.
Better than expected
NYSE
Primerica, Inc. reports a significant increase in net income and EPS for Q3 2025, driven by robust performance in its Investment and Savings Products segment.
Better than expected
NYSE
Primerica reports increased net income driven by the absence of prior-year discontinued operations, while core business segments show mixed performance with strong investment product sales but declining recruitment.
NYSE
Primerica's Q1 2025 results show a significant increase in net income, driven by growth in the Investment and Savings Products segment and a solid performance in Term Life Insurance.
Better than expected
NYSE
Primerica's Q3 2024 results show a mixed performance with increased revenues offset by losses from discontinued operations and adjustments to future policy benefit assumptions.
Worse than expected
NYSE
Primerica's Q2 2024 results show a net loss due to a significant impairment charge in its Senior Health segment, despite revenue growth in other areas.
Worse than expected
Annual Reports (10-K)
NYSE
Primerica, Inc. delivered robust financial performance in 2025 with significant revenue and net income growth from continuing operations, alongside increased shareholder returns.
Better than expected
NYSE
Primerica's 2024 10-K filing highlights a growing sales force, strategic adjustments including the abandonment of e-TeleQuote, and a focus on digital capabilities.
Worse than expected
NYSE
Primerica's 2023 10-K filing highlights its continued growth in sales force and client base, alongside a focus on regulatory compliance and strategic initiatives.
Better than expected
Insider Trading (Form 4)
NYSE
Director Barbara Yastine acquired 58.305 shares of Primerica, Inc. common stock through a dividend reinvestment plan.
NYSE
Primerica, Inc. Director Donald R. Williams acquired 42.288 shares of common stock via dividend reinvestment.
NYSE
Director Cynthia N. Day acquired 87.218 shares of Primerica, Inc. common stock through a dividend reinvestment plan.
NYSE
Director Amber Cottle acquired 12.47 shares of Primerica common stock through a dividend reinvestment plan.
NYSE
Director Joel M. Babbit acquired 35.6116 shares of Primerica, Inc. common stock through a dividend reinvestment plan.
NYSE
Primerica CEO Glenn J. Williams sold 1,500 shares of common stock at an average price of $280.49 per share.
Proxy Statements (Def-14A)
NYSE
Primerica, Inc. announced solid financial performance in fiscal 2025 with increased revenue and profit, alongside mixed distribution results and strong long-term shareholder returns.
Better than expected
NYSE
Primerica, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 14, 2025, outlining key proposals for voting.
NYSE
Primerica's proxy statement outlines proposals for the upcoming annual meeting, including the election of directors, an advisory vote on executive compensation, and ratification of the company's independent auditor.
Better than expected
NYSE
Primerica, Inc. announces its 2024 Annual Meeting of Stockholders to be held on May 8, 2024, outlining key voting items including the election of directors, an advisory vote on executive compensation, and the ratification of KPMG LLP as the independent auditor.
NYSE
Primerica's 2024 proxy statement outlines key governance practices, executive compensation details, and matters for stockholder voting at the upcoming annual meeting.
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management reports beneficial ownership of 5.29% of Primerica Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.79% of Primerica Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G for Primerica Inc., reporting 0% beneficial ownership following an internal corporate realignment.
NYSE
SCHEDULE 13G/A: Baron Capital Group Maintains Significant Passive Stake in Primerica, Inc. Below 5% Threshold
Baron Capital Group, along with its affiliates BAMCO, Inc. and Baron Capital Management, Inc., and Ronald Baron, has filed an Amendment No. 13 to their Schedule 13G, reporting a continued passive beneficial ownership of 4.96% in Primerica, Inc. as of December 31, 2024.